Latest News

• share
• favorite_border

The American College of Academic Addiction Medicine (ACAAM) today announced the appointment of Bruce E. Hammond, Jr., CAE, as Executive Director, effective January 1, 2021. Mr. Hammond will step into the new position following the long-planned end-of-year retirement of Kevin Kunz, M.D., M.P.H., DFASAM, founding ACAAM President (2008) and Executive Vice President since 2013. ACAAM was formerly known as The ABAM Foundation and The Addiction Medicine Foundation.

• share
• favorite_border

Today, Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the U.S., announced that it received FDA Emergency Use Authorization (EUA) and is scaling up capacity for CRL Rapid Response™, a saliva-based COVID-19 RT-PCR test that can be self-collected at home, work or any other setting.

• share
• favorite_border

Three female scientists have been named Laureates of the Blavatnik National Awards for Young Scientists, each receiving $250,000, the largest unrestricted scientific prize offered to America’s most-promising, faculty-level scientific researchers. It marks the first time in the program’s 13-year history that all of the recipients are women.

• share
• favorite_border

Atlantic Health System, an integrated health care delivery system, today announced a partnership with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and Origin Commercial Ventures to create a new platform to deliver economically viable immunotherapies and other breakthrough cancer treatments to the region through expedited access and novel payment options.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the three winners and six finalists of the 2018 Blavatnik Regional Awards for Young Scientists.

• share
• favorite_border

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator (PI) on the first trial and as local PI on three other trials.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the 2018 Laureates of the Blavatnik National Awards for Young Scientists, who will each receive $250,000: the largest unrestricted scientific prize offered to America’s most promising faculty-level scientific researchers 42 years of age and younger.

• share
• favorite_border

The Blavatnik National Awards for Young Scientists today announced the 31 U.S. National Finalists who will compete for the world’s largest unrestricted prizes for early career scientists. Each year, three Blavatnik National Laureates in the categories of Life Sciences, Chemistry, and Physical Sciences & Engineering are awarded $250,000 each.

• share
• favorite_border

Following successful Phase 1 clinical trials, the Toca regimen – a new immunotherapy for patients with recurrent brain cancer – has advanced to a Phase 3 study, which is currently underway. The trial is being conducted at 68 sites across the United States, Canada, Israel and South Korea, including at Overlook Medical Center’s Gerald J. Glasser Brain Tumor Center, one of three clinical trial sites in New Jersey. In this surgical study, patients are randomized to either standard of care treatment or the Toca regimen. Enrollment is expected to complete in this trial by the end of 2018.

• share
• favorite_border

Atlantic Health System’s new Atlantic HPV Center is one of a small number of research centers in the nation to begin a study to determine whether an innovative combination of immuno-oncology treatments is safe, shows preliminary efficacy and provokes an anticancer immune system response in patients with recurrent or metastatic human papilloma virus (HPV) associated head and neck squamous cancer.

• share
• favorite_border

Two landmark developments in medicine pave the way for quality medical care to address America’s largest and most costly preventable health problem – unhealthy substance use and addiction involving all addictive substances. These changes are designed to increase the number of addiction medicine physician specialists who can provide direct patient care and consultation, teach other providers and thereby drive knowledge across health care, and help policymakers and the public understand and effectively respond to our current health crisis.

• share
• favorite_border

The Gerald J. Glasser Brain Tumor Center of Overlook Medical Center’s Atlantic Neuroscience Institute and Carol G. Simon Cancer Center is one of four sites in the country to begin a Phase III clinical trial of the novel drug VAL-083 for patients whose glioblastoma multiforme or gliosarcoma has progressed during or after treatment with the standard of care chemo-radiation therapy. Other study locations are: Kaiser Permanente Los Angeles Medical Center; University of California, San Francisco; and Dent Neurosciences Research Center, Amherst, NY.

• share
• favorite_border

Mohamad Cherry, MD, leads a major session on new discoveries about the most common type of acute adult leukemia and helps present results of four major blood cancer studies at the American Society of Hematology (ASH) 59th Annual Meeting, December 9-12 in Atlanta, GA. The meeting is the world’s pre-eminent gathering of clinicians and researchers focused on blood diseases, who travel from nearly 100 countries to hear the latest research developments. An internationally known hematology/oncology researcher, Dr. Cherry recently joined Atlantic Hematology Oncology, part of Atlantic Health System’s Atlantic Medical Group at Morristown Medical Center’s Carol G. Simon Cancer Center, from the University of Oklahoma Health Sciences Center’s Stephenson Cancer Center.

• share
• favorite_border

Nationally renowned gastrointestinal (GI) cancer physician-scientist Angela Alistar, MD thinks it is critical that everyone learn how to recognize the warning signs of pancreatic cancer. Dr. Alistar is medical director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the three Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young Scientists. Established in 2007, the Awards are given annually by the Blavatnik Family Foundation and administered by the New York Academy of Sciences to honor the excellence of outstanding postdoctoral scientists from institutions across New York, New Jersey and Connecticut.

• share
• favorite_border

According to a new study, frontotemporal degeneration (FTD), the most common dementia for people under age 60, inflicts a much more severe economic burden on patients and their caregivers than Alzheimer’s disease, as well as other forms of dementia that typically show their first symptoms later in life.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the 2017 Laureates of the Blavatnik National Awards for Young Scientists. Starting with a pool of 308 nominees – the most promising scientific researchers aged 42 years and younger nominated by America’s top academic and research institutions.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the Finalists for the 2017 Blavatnik National Awards for Young Scientists. From a pool of 308 nominees – the most promising scientific researchers aged 42 years and younger at America’s top academic and research institutions – the 30 Finalists will now compete for the largest unrestricted awards of their kind for early career scientists and engineers.

• share
• favorite_border

The Addiction Medicine Foundation today announced the accreditation of two additional fellowship programs to train addiction medicine physicians. The Foundation has supported the establishment of 44 addiction medicine fellowship training programs to date, based at major medical schools and teaching hospitals across North America, and is committed to establishing a total of 125 Accreditation Council for Graduate Medical Education-accredited addiction medicine fellowship programs by 2025.

• share
• favorite_border

The Alzheimer’s Drug Discovery Foundation (ADDF) announced today the relaunch of CognitiveVitality.org, its brain health and dementia prevention website. The streamlined, easy-to-navigate site separates fact from fiction and empowers people to make smarter choices for their brain health.

• share
• favorite_border

The Blavatnik Family Foundation and the New York Academy of Sciences today announced the three winners and six finalists of the 2016 Blavatnik Regional Awards. The winners include an ecologist who has advanced our understanding of how forest ecosystems recover or die during drought; a physical chemist who studies electron transport in solar energy capture and conversion; and a condensed matter physicist who has provided theoretical guidance to experiments that have led to the direct observation of Majorana fermions. The six finalists perform pioneering research in diverse areas including astrophysics, engineering, biochemistry and structural biology, molecular and cellular biology, theoretical chemistry, and biomedical engineering.

• share
• favorite_border

The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna® for use as a cancer therapy) in patients with Alzheimer’s disease.

• share
• favorite_border

Medicinal chemist and pharmacologist Daniel Martin Watterson, PhD, has been named the second annual winner of the Alzheimer’s Drug Discovery Foundation’s (ADDF) Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. The prize is the first to specifically recognize researchers working in promising areas of drug discovery for Alzheimer’s disease and related dementias. Dr. Watterson is the John G. Searle Professor of Molecular Biology and Biochemistry and Professor of Pharmacology at Northwestern University’s Feinberg School of Medicine. He also serves in an advisory role to pharmaceutical and biotechnology companies.

• share
• favorite_border

The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration announce The Treat FTD Fund, a $10 million investment to develop effective treatments for frontotemporal degeneration, a complex form of dementia that affects more than 50,000 people in the United States. The fund was created thanks to a commitment of $5 million from The Lauder Foundation and Ronald S. Lauder, and $5 million from the Samuel I. Newhouse Foundation.

• share
• favorite_border

The Addiction Medicine Foundation (formerly The ABAM Foundation) today announced the winners of the Next Generation Award for Adolescent Substance Use Prevention. The awards of $25,000 each, which are conferred by the Foundation’s National Center for Physician Training in Addiction Medicine and partially funded by the Conrad N. Hilton Foundation.

• share
• favorite_border

Andrew Elkwood, MD, FACS and Matthew R. Kaufman, MD, FACS, leading plastic and reconstructive surgeons at The Institute for Advanced Reconstruction at The Plastic Surgery Center, will present new findings based on their work in advanced reconstructive techniques for people with spinal cord injuries and pain disorders at two upcoming scientific meetings.

• share
• favorite_border

The Addiction Medicine Foundation today announced the accreditation of four additional fellowship programs to train addiction medicine physicians. The Foundation has supported the establishment of 40 addiction medicine fellowship training programs to date, based at major medical schools and hospitals across North America.

• share
• favorite_border

The American Board of Medical Specialties (ABMS) announced today the recognition of Addiction Medicine as a new subspecialty. The American Board of Preventive Medicine (ABPM), a Member Board of ABMS, sponsored the application for the new field to be a multispecialty subspecialty – meaning that physicians certified by any Member Board of the ABMS can become certified in addiction medicine. The ABMS subspecialty recognition of Addiction Medicine has been championed by the American Board of Addiction Medicine (ABAM), which has established a certification examination and Maintenance of Certification (MOC) process for addiction medicine physicians.

• share
• favorite_border

More than 100 of the world’s leading Alzheimer’s drug researchers will gather today and tomorrow at the Hyatt Regency Jersey City to hear the latest developments in the discovery and testing of promising drugs, detection technologies, biomarkers and newly discovered therapeutic targets for preventing, treating and curing Alzheimer’s disease and related dementias. Organized and hosted by the Alzheimer’s Drug Discovery Foundation, the conference is the only scientific meeting dedicated solely to bringing leading academic and industry scientists together to present new research on Alzheimer’s drug discovery and establish partnerships to further their studies.

• share
• favorite_border

The American Board of Addiction Medicine (ABAM) Foundation today announced the accreditation of nine additional fellowship programs to train addiction medicine physicians. With the addition of these programs, the total number of ABAM Foundation accredited training programs has reached 36.

• share
• favorite_border

Physician-scientist Frank M. Longo, MD, PhD, has been named the inaugural winner of the Alzheimer’s Drug Discovery Foundation’s Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery, the first prize to specifically recognize researchers working in novel and promising areas of Alzheimer’s drug discovery. Dr. Longo is Professor and Chairman of the Department of Neurology and Neurological Sciences at Stanford University School of Medicine and founder and Chairman of biopharmaceutical firm PharmatrophiX.

• share
• favorite_border

Thanks to the generosity of former Warner-Lambert CEO and Chairman Melvin R. Goodes and his family, the Alzheimer’s Drug Discovery Foundation (ADDF) has established the only prize specifically recognizing scientists in Alzheimer’s drug discovery research. Mr. Goodes—who has been open about his own Alzheimer’s diagnosis—is an honorary member of the ADDF’s Board of Governors. He and his wife, Nancy, who is also on the ADDF’s Board of Governors, are outspoken advocates for Alzheimer’s research.

• share
• favorite_border

A chemist who has made important discoveries in both the human brain and sustainable energy, a neurosurgeon who has done pioneering work mapping the “blueprint” of how humans speak and hear, and a computer scientist who has changed our understanding of the capacity of wireless networks are the three winners of the 2015 Blavatnik National Awards for Young Scientists.

• share
• favorite_border

Migraine researchers and clinicians are excited about a new class of drugs called Calcitonin Gene-Related Peptide (CGRP) monoclonal antibodies, which are showing promise in preventing attacks in high-frequency episodic migraine and chronic migraine. Numerous studies on these medications are being presented at this week's American Headache Society scientific meeting.

• share
• favorite_border

Researchers and clinicians worldwide working in migraine, headache and brain injury will share the field’s latest scientific advances at American Headache Society’s annual scientific meeting, June 18-21 in Washington, DC. Stories are embargoed until June 17.

• share
• favorite_border

To encourage openness in research and the teaching of best practices in social science, the Berkeley Initiative for Transparency in the Social Sciences (BITSS) announces that entries are being accepted for the new Leamer-Rosenthal Prizes for Open Social Science. BITSS is an initiative of the Center for Effective Global Action (CEGA) at the University of California, Berkeley.

• share
• favorite_border

With the goal of educating the public about the dangers of sports-related concussion and the debilitating migraine attacks that often result, Daniel Newman has won first place in Nikon Inc.’s “I Am Next” contest, with a dramatic photo of his brother Eric, who has experienced the after-effects of sports-related concussions. Daniel’s entry rose to the top of more than 14,000 contest submissions.

• share
• favorite_border

Some studies show migraine affects 6% of children and up to 28% of adolescents ages 15-17. To assist parents whose children suffer from migraine, and to help the children themselves, the American Migraine Foundation and its Chair, David W. Dodick, MD, FRCP (C) are offering a number of tips to help manage childhood migraine and minimize its impact. Dr. Dodick is Professor of Medicine at the Mayo Clinic College of Medicine.

• share
• favorite_border

The American Board of Addiction Medicine (ABAM) today announced that 651 physicians passed its most recent addiction medicine certification examination, while The ABAM Foundation accredited four additional fellowship programs to train new addiction medicine physicians.

• share
• favorite_border

The January issue of the American Headache Society journal Headache provides an updated assessment of the best treatments to use when a migraine attack occurs. The assessment will form the basis of new AHS treatment guidelines. The paper was authored for the AHS by leading headache specialists Michael J. Marmura, MD and Stephen D. Silberstein, MD, FACP, both of the Jefferson Headache Center of Thomas Jefferson University, and by Todd J. Schwedt, MD, MSCI, of the Department of Neurology, Mayo Clinic Arizona.

• share
• favorite_border

In a new study led by Alan B. Ettinger, M.D., M.B.A., Director of the Epilepsy Center at Neurological Surgery, P.C. and Professor of Clinical Neurology, Albert Einstein College of Medicine, nearly one in five adult epilepsy patients reported attention deficit hyperactivity disorder (ADHD) symptoms. This is four times higher than the approximate 4.4% rate of ADHD diagnosis in the general adult population.

• share
• favorite_border

The American Migraine Foundation seeks to create the first Migraine Patient Registry and Biorepository – an international database of information on every person who has migraine, along with a collection of physical samples of saliva, blood and other genetic materials and biological fluids, and brain images – all of which can be used when conducting migraine research.

• share
• favorite_border

Studies have shown that periods of high stress and poor sleep can combine to increase the risk of having a migraine attack. Because stress levels are often high – and sleep insufficient -- during the winter holiday season, the American Migraine Foundation and its Chair, David W. Dodick, MD, FRCP (C), FACP, want to help people with migraine better understand some essentials of sleep hygiene that may help reduce their risk of migraine attacks. Dr. Dodick is also Professor of Medicine at the Mayo Clinic College of Medicine.

• share
• favorite_border

Certain foods and drinks can trigger migraine in many people, and those who suffer from migraines need to be especially careful to avoid these triggers as they attend holiday celebrations. The American Migraine Foundation and Chair David W. Dodick, MD, FRCP (C), FACP, want to help people with migraine avoid these potential triggers, so that they can better enjoy the season. Dr. Dodick is Professor of Medicine at the Mayo Clinic College of Medicine.

• share
• favorite_border

The American Migraine Foundation announced today that its website, www.AmericanMigraineFoundation.org, has been thoroughly redesigned and expanded to provide a wealth of consumer-friendly information on preventing, treating and coping with migraine and other headache disorders.

• share
• favorite_border

In a new JAMA Internal Medicine article, three leading addiction experts document the need for an addiction medicine specialty, trace the history of physicians specializing in addiction treatment, and discuss current efforts by the American Board of Addiction Medicine and The ABAM Foundation to train and certify physicians, and to become recognized and accredited within the larger medical community.

• share
• favorite_border

Drawing on the lessons of Superstorm Sandy, a new report from The New York Academy of Medicine (NYAM), “Resilient Communities: Empowering Older Adults in Disasters and Daily Life,” presents an innovative set of recommendations to strengthen and connect formal and informal support systems to keep older adults safe during future disasters.

• share
• favorite_border

A team of researchers reporting at the 56th Annual Scientific Meeting of the American Headache Society found that migraine attack frequency is higher in women during peri-menopause and menopause than in pre-menopause. During pre-menopause, periods are typically regular. During the menopausal transition or “peri-menopause” menstrual periods become irregular and at menopause, menstrual periods stop.

• share
• favorite_border

More than a dozen of the world’s top migraine and headache doctors will participate in the American Headache Society’s (AHS) 2nd Annual TweetChat, as part of the AHS Annual Scientific Meeting.

• share
• favorite_border

Researchers and clinicians worldwide working in migraine, headache and brain injury share the field’s latest scientific advances at American Headache Society’s annual scientific meeting in Los Angeles.